Suggestibility enhancement from Myristicin

Suggestibility enhancement refers to an increased susceptibility to accepting and acting upon ideas, interpretations, and directions from external sources -- other people, environmental cues, music, or media -- during psychoactive substance use. The individual's normal critical evaluation of incoming information is relaxed, and proposals that might be questioned, analyzed, or rejected in a sober state are more readily accepted and internalized.

The cognitive basis of suggestibility involves the weakening of top-down predictive processing -- the brain's usual approach of testing incoming information against established beliefs, expectations, and prior knowledge. When this predictive framework is relaxed (as occurs with psychedelics, hypnotics, and some dissociatives), the brain becomes more receptive to novel information and external influence because it is less actively filtering and rejecting input that conflicts with existing mental models.

Psychedelics produce suggestibility enhancement through their characteristic disruption of the default mode network (DMN) and the relaxation of prior beliefs (described in the REBUS model -- RElaxed Beliefs Under Psychedelics). This neurological state is believed to be a key therapeutic mechanism in psychedelic-assisted therapy, where a trained therapist can help guide the individual's heightened openness toward therapeutic insight, trauma processing, and adaptive belief revision.

However, enhanced suggestibility also creates vulnerability. In non-therapeutic contexts, suggestible individuals may be more susceptible to manipulation, persuasion to engage in activities they would normally decline, adoption of beliefs or ideologies presented by others during the experience, and emotional contagion (being strongly affected by others' emotional states). This is why the ethics of psychedelic facilitation emphasize the importance of the facilitator maintaining appropriate boundaries and avoiding imposing their own beliefs on the participant.

Hypnotic substances (certain benzodiazepines, GHB at certain doses, some dissociatives) can produce suggestibility enhancement through different mechanisms -- primarily by reducing the inhibitory function of the prefrontal cortex that normally modulates the acceptance of external input. This type of pharmacologically enhanced suggestibility has serious implications for vulnerability to exploitation.

Dissociatives can produce suggestibility through their general disruption of normal cognitive processing, particularly the weakening of self-referential evaluation that normally serves as a filter for incoming suggestions. In a dissociated state, the usual process of asking "does this make sense to me?" is impaired.

The therapeutic implications of suggestibility enhancement are profound and double-edged. In the hands of a skilled, ethical therapist, enhanced suggestibility is a powerful tool for helping individuals overcome rigid maladaptive patterns. In unsafe contexts, it represents a significant vulnerability that requires awareness and appropriate safeguards.